Your search for

24 results were returned

  1. Legal news
    04 November 2019
    Are German Courts the “Spoilsport” of the “Divisional Game” when it comes to Preliminary Injunction Requests?

    If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...

  2. Legal news
    11 May 2020
    COVID-19: New German legislation to fight pandemic may affect granted German patents

    In the wake of the COVID-19 pandemic the German government has recently passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, the ...

  3. Legal news
    14 January 2019
    New Decision: Higher Regional Court Düsseldorf on Second Medical Use Patents

    Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).

  4. Legal news
    31 July 2018
    SPC News: Court of Justice of the European Union rules in re Truvada

    On July 25, 2018, the Court of Justice of the European Union (CJEU) handed down its newest SPC decision in re Truvada (C-121/17).

  5. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

  6. Legal news
    05 December 2018
    Patents: SPCs: combined medical device and medicinal product

    This decision follows the recent trend for the ECJ to give more straightforward interpretations of the SPC Regulation, providing certainty for users of the system.

  7. Legal news
    24 July 2017
    Federal Patent Court grants compulsory license

    The grant of a compulsory licence for the distribution of MSD’s HIV medicament “Isentress” (generic name raltegravir) by the German Federal Patent Court following the oral hearing on 30 and 31 August 2016 constitutes a ...